ISPC · iSpecimen Inc.
Price & Indicators
Raw chart and full-history price indicators begin at the captured split on Apr 28, 2026; bars on opposite sides are not compared.
The closing range begins at the captured split on Apr 28, 2026.
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ISPC
this stock
iSpecimen Inc.
|
$3.88M | — | -79.2% | — | 5.9% |
|
TMO
Thermo Fisher Scientific Inc.
|
$230.05B | +6.5% | +14.5% | 33.5 | 1.3% |
|
DHR
Danaher Corp /De/
|
$147.09B | -6.7% | +8.5% | 37.1 | 1.2% |
|
NTRA
Natera, Inc.
|
$47.03B | +40.5% | -2.8% | — | 3.0% |
|
IDXX
Idexx Laboratories Inc /De
|
$43.72B | -17.7% | +10.4% | 39.0 | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
Raw-price comparisons begin at the captured split on Apr 28, 2026; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ISPC | -1.9% | -23.4% | — | -18.5% | — |
| SPY | +0.5% | +1.2% | +13.3% | +2.7% | +12.5% |
| vs SPY | -2.4% | -24.6% | — | -21.2% | — |